Eden Research (LON:EDEN) Stock Price Down 13.2% – Time to Sell?

Eden Research plc (LON:EDENGet Free Report) dropped 13.2% during mid-day trading on Monday . The stock traded as low as GBX 2.26 ($0.03) and last traded at GBX 2.37 ($0.03). 1,775,147 shares were traded during mid-day trading, an increase of 133% from the average session volume of 762,776 shares. The stock had previously closed at GBX 2.73 ($0.04).

Eden Research Stock Performance

The company has a quick ratio of 2.42, a current ratio of 3.80 and a debt-to-equity ratio of 1.26. The firm has a fifty day simple moving average of GBX 3.41 and a 200-day simple moving average of GBX 3.74. The company has a market cap of £12.64 million, a PE ratio of -8.30 and a beta of 0.92.

Insider Activity at Eden Research

In other news, insider Lykele van der Broek purchased 256,000 shares of the company’s stock in a transaction dated Thursday, February 6th. The shares were acquired at an average cost of GBX 4 ($0.05) per share, for a total transaction of £10,240 ($13,229.97). Also, insider Alexander John Abrey acquired 167,947 shares of Eden Research stock in a transaction that occurred on Tuesday, March 4th. The stock was purchased at an average price of GBX 3 ($0.04) per share, with a total value of £5,038.41 ($6,509.57). Insiders acquired a total of 964,487 shares of company stock worth $3,690,001 in the last 90 days. 14.02% of the stock is owned by insiders.

About Eden Research

(Get Free Report)

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.

Recommended Stories

Receive News & Ratings for Eden Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eden Research and related companies with MarketBeat.com's FREE daily email newsletter.